Pfizer Stock Price Pulls Out Of Dive
12838
Pfizer Inc. shares staged a rebound Tuesday, spurred in part by what Wall Street viewed as positive publicity about its Celebrex drug.
466550
Credit Suisse First Boston lowered 2005 earnings estimates for Pfizer (nyse: PFE - news - people ) after the generic version of Neurontin was launched earlier than expected.
753455
Pfizer to investors: Don't stop believing.
335324
NEW YORK - Pfizer Inc  said on Thursday third-quarter earnings fell sharply due to a $2.8 billion charge to end its involvement with the poorly selling inhaled insulin drug Exubera.
599021
Stock futures pointed to a flat market opening on Monday, with Pfizer Inc.  shares in focus after news that it had halted development of one of its key experimental drugs.
140351
NEW YORK - Investors sent stocks sharply lower Thursday as oil prices continued their climb higher and new questions about the safety of arthritis drugs pressured pharmaceutical stocks. The Dow Jones industrials, which include drug makers Pfizer Inc...
217263
Shares of Pfizer Inc. PFE.N closed  down more than 2 percent on Monday after an analyst lowered her  investment rating on the world's largest pharmaceutical  company's stock.
372947
Stocks of branded and generic drug makers closed down a bit Tuesday as clinical study results mixed with merger updates. One of the big winners on the day was Nektar Therapeutics, on news that Exubera, the
203287
U.S. stocks rallied on Tuesday, with the Dow closing at its highest level in 3 1/2 years, boosted by a rebound in beaten-down drugmaker Pfizer Inc. , while tech stocks got a lift from a broker upgrade of Intel Corp. .
108463
Pfizer is a good company, but a bad stock for 2008.
49327
Pfizer Inc.  shares  tumbled as much as 15.6 percent on Monday, wiping out nearly  $30 billion of market value, after the world's biggest drug  maker unexpectedly ended development of its most important  experimental medicine.
56524
Shares in US drugmaker Pfizer plunge after it halts development of its most important experimental drug.
624069
Stocks looked set to open little changed on Monday, with Pfizer Inc.  shares tumbling after news that it had halted development of one of its key experimental drugs, while merger deals lifted views on the economy's health.
21245
Pfizer Inc.&#39;s shares continued to rebound Wednesday, gaining 4 percent during the day&#39;s trading, as industry analysts continued to sort out the most recent studies involving its Celebrex drug.
585524
U.S. stocks rallied on Tuesday, with  the Dow closing at its highest level in 3 1/2 years, boosted by  a rebound in beaten-down drugmaker Pfizer Inc. PFE.N, while  tech stocks got a lift from a broker upgrade of Intel Corp.  INTC.O.
64708
Shares of Merck &amp; Co. plunged nearly 27 percent yesterday, pulling other stocks down with it, after the pharmaceutical giant yanked its Vioxx arthritis drug off the market because of heart safety concerns.
543424
Pfizer Inc. reaffirmed its full-year guidance Wednesday despite a 48 percent drop in second-quarter profit because of lagging sales of cholesterol drug Lipitor and generic competition for Zoloft and Norvasc.